Verastem Appoints Michael P. Bailey as New CEO, Replacing Daniel Paterson
Biopharma veteran Michael P. Bailey will assume the role of President and CEO on January 1, 2027, to lead the company's commercial growth and pipeline strategy.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed